The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I agree language unnecessary, but also agree that more likely to fall back further from here.
I'm waiting until it's back below 8 before replacing those I sold yesterday. I may miss out, but at least I'll preserve my capital
I think you are more likely to cry if you want to
Overbought this time last year on wave of general green enthusiasm plus promise of loads of deals closing. Then dropped back as that wave receded, and further fell as targets missed. Still way above where it was 18-24 months ago (0.2p); and placing in 2019. But I think current price includes an expectation that deals will be concluded. If they are not expect further falls. How much it rises from here depends on what deals are concluded. Still a large holding for me though I've taken some profits. Hoping for 2p+ later this year, possibly much higher if DP really delivers. But also resigned to possibility of dropping sub 1p if ongoing delays.
I went to see the new Joel Coen version of Macbeth last night in our local cinema which has a great (proper) restaurant attached.
Great meal, good company, and then a fantastic film on the big screen. No way would that have been anywhere near the same experience at home
Glad I topped up with the recent fall
@tinysquid: 25 posts in last 30 days, all on cine. Something tells me you've got an agenda, and you're not being honest. Filtered.
From the original article (as opposed to a misleading tweet): this is the probability of an infection being Omicron given a person is infected, so it doesn’t tell us how likely a person is to test positive in the first place. This means it doesn’t tell us that the vaccines are making things worse overall, only that they are making it much more likely that a vaccinated person is infected with Omicron than another variant. In other words, it is a measure of how well Omicron evades the vaccines compared to Delta. The fact that the triple-vaccinated are much more likely to be infected with Omicron than the double-vaccinated confirms this vaccine evading ability.
I've ordered two packs of home LFT in past week, both arrived within 24hrs.
Shame they're not ours but there you go
Big write up on Extreme E in Guardian sport, though no mention of AFC, and being the Guardian plenty of questions about Saudi links
https://www.theguardian.com/sport/blog/2021/dec/18/alejandro-agag-extreme-e-first-sport-with-climate-crisis-at-heart-motor-sport
Alan McNally, a professor in microbial genomics at the University of Birmingham who helped set up the Milton Keynes Lighthouse Lab, said PCR tests were already pointless in the Omicron epidemic. “At current doubling rates, by New Year’s Day Omicron will be infecting 1 million people per day. PCR testing is a completely pointless exercise,” he said. “The outbreak is doubling quicker than you get a PCR result. It is now a useless tool.”
Sounds like what we need is a quick and accurate test.....come on ODX
Alan McNally, a professor in microbial genomics at the University of Birmingham who helped set up the Milton Keynes Lighthouse Lab, said PCR tests were already pointless in the Omicron epidemic. “At current doubling rates, by New Year’s Day Omicron will be infecting 1 million people per day. PCR testing is a completely pointless exercise,” he said. “The outbreak is doubling quicker than you get a PCR result. It is now a useless tool.”
Sounds like what we need is a quick and accurate test
I thought I read in one of their releases that increased returns might in part be due to people buying more fitted rather than loose wear, and thus increased likelihood of the fit not being good enough.
I've just topped up; it may still fall from here but longer term I think they will do OK
I'm afraid that's nonsense, albeit something that pops up all too frequently
have a read of the T&C of your nominee account
I thought I'd reread the RNS from September. Call it what you like, but they seem pretty confident in the underlying business and medium term outlook.
None of us know what next month or two will bring, but beyond that shares are looking attractive at these prices if you're willing to hold for a while.
Agreed - I see this as an opportunity for SNG if trial results positive - indicates a willingness by the NHS & UK government to start treatment early in those at high risk.
I think the cost of treatment will preclude it being used more widely outside of hospital in lower risk populations
Current NHS strategy: if trial data positive for SNG as we hope, this may be an opportunity for us:
Highest risk covid patients are now eligible for out of hospital antiviral/monoclonal antibody treatment.
Most of the highest risk patients will receive a letter or email telling them in advance they
may be eligible for these treatments in the event they test PCR positive for COVID-19.
They will also automatically receive a priority PCR test to keep at home.
Each integrated care system (ICS) has established one or more local CMDU to roll out
nMABs or antivirals as a treatment for COVID-19. The majority of CMDUs are based in
hospital settings.
These treatments must be delivered quickly following symptom onset.
I fear there may be a rash of red dots under there
@stas20: good summary.
Lots of fantasists on here, good to have a dose of realism. Been a pretty disappointing year and a half for those dreaming of untold riches, although some judicious top slicing and buying the dips has meant I was in profit until the RNS landed.
Look at GDR indeed, countless other examples, BIDS today; Simec this week.
Placing probably on the way. If you're confident enough that's coming sell what you own now and buy back cheaper. Or simply average down when the placing comes
I don't think the company is going bust. It will likely be a rollercoaster for a while. Hold your nerve and there's money to be made if you can time it right. But reward doesn't come without risk. All those ****ging off the management may have a point; but they are also hoping for triple digit percentage returns and there is no such thing as a free lunch
poor timing from me: I added to my (already significant) holding just before that came out
depending on outcome of this price monitoring extension, my mini sale is either going to be seen as fortuitous or exquisitely badly timed
I'm wondering the same - just seen this.
I don't think it was the small sale I just did to free up some funds for a punt on another share
Still heavily invested here, would love to see a big rise today